Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $41.31 USD
Change Today -0.15 / -0.36%
Volume 184.9K
LDOS On Other Exchanges
New York
As of 8:04 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

leidos holdings inc (LDOS) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/23/15 - $47.18
52 Week Low
09/9/14 - $31.76
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LEIDOS HOLDINGS INC (LDOS)

leidos holdings inc (LDOS) Related Businessweek News

No Related Businessweek News Found

leidos holdings inc (LDOS) Details

Leidos Holdings, Inc. operates as an applied technology company in the United States. It operates through National Security Solutions (NSS), and Health and Engineering (HES) segments. The NSS segment offers solutions and systems for air, land, sea, space, and cyberspace for the U.S. intelligence community, the U.S. department of defense, military services, the U.S. department of homeland security, and government agencies of U.S. allies abroad. Its solutions offer technology, intelligence systems, command and control, data analytics, cybersecurity, logistics, and intelligence analysis and operations support services to critical missions. The HES segment offers electronic health record (EHR) system and behavior health services; implements and optimizes EHR systems at commercial hospitals; and provides consulting and operational support services for ICD-10 transition, IT strategy, revenue cycle management, accountable care transformation, risk management, technology infrastructure, and project management. It also provides life science research and development support services to the National Institute of Health, Center for Disease Control, Army Medical Research community, commercial biotech companies, and the Frederick national laboratory for cancer research in genetics and genomics, proteins and proteomics, biomedical computing and information technology, biopharmaceutical development and manufacturing, nanotechnology characterization, and clinical trials management areas. In addition, this segment offers process industries engineering services and solutions to mid-tier refineries and industrial companies; security products, services, and solutions; power grid engineering services and solutions; engineering and consulting services to electric utilities and transmission companies; federal environmental and engineering services; and transaction and asset valuation services for the power industry. The company was founded in 1969 and is headquartered in Reston, Virginia.

19,000 Employees
Last Reported Date: 03/25/15
Founded in 1969

leidos holdings inc (LDOS) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $2.4M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $640.0K
President of National Security Solutions
Total Annual Compensation: $546.2K
Executive Vice President and General Counsel
Total Annual Compensation: $574.7K
Chief Human Resources Officer and Executive V...
Total Annual Compensation: $375.4K
Compensation as of Fiscal Year 2015.

leidos holdings inc (LDOS) Key Developments

Leidos Receives $25 Million Task Order from Defense Intelligence Agency

Leidos was awarded a task order by the Defense Intelligence Agency (DIA) Americas Regional Center (AMRC) to provide all-source intelligence analysis. The single-award, cost-plus fixed-fee contract has a five-year period of performance including base period and all option periods for a total contract value of approximately $25 million if all options are exercised. Work will be performed on Joint Base-Anacostia-Bolling in Washington, DC. The task order was awarded under the DIA Solutions for Intelligence Analysis II contract. The DIA provides military intelligence to warfighters, defense policymakers, and force planners in the Department of Defense (DoD) and the Intelligence Community (IC), in support of U.S. military planning and operations and weapon systems acquisition. Under the contract, Leidos will assist DIA AMRC in all-source analysis with an emphasis on counter-narcotics trafficking, social network/open-source analysis, and transnational organized crime finance analysis. Leidos will also support the needs of the Defense Critical Infrastructure Program.

United States Army Awards $7.2 Billion Prime Contract to Leidos

Leidos was awarded a prime contract by the United States Army Intelligence and Security Command (INSCOM) to provide global intelligence support services. The multiple-award indefinite-delivery/indefinite-quantity contract has a five-year period of performance and a total contract ceiling of $7.2 billion ($5 billion for full and open and $2.2 billion for small business awardees). Leidos is one of thirteen large business contractors eligible to compete for task orders under the contract.

Former Executive Seeks $45 Million in Lawsuit against Leidos Holdings, Inc

A former Leidos Holdings Inc. executive is accusing the Reston-based government contractor of discrimination and wrongful termination and alleging the company and its former CEO defamed him. In an amended complaint filed March 30 in U.S. District Court in Alexandria, Joseph Craver, a former president of the company's health and engineering sector, alleges Leidos and former CEO John Jumper fired him in December 2013 because he was diagnosed with Parkinson's disease. Craver is seeking more than $45 million in damages in the case, which was originally filed May 8, 2014, in the Virginia Circuit Court of Fairfax and moved to federal court in March. Craver's lawsuit claims his termination was because of a perception that his Parkinson's disease diagnosis 'substantially limited his major life activities, even though there was no basis for this perception. An attorney for Leidos and Jumper did not respond to a request for comment. According to the court filing, Craver said he was always in good standing with the company, enjoying a successful and lucrative career that began as a staff engineer. Craver claims the severance package did not fairly compensate him for his nearly 25 years of service to Leidos and its previous incarnation as Science Applications International Corp., the suit alleges. It also claims Leidos cut off his stock options that were to vest in the next 15 months. Craver also claims Leidos and Jumper defamed him in a statement that appeared in a March 14 online post in theWashington Business Journal. Craver's complaint said the statement made it impossible to find other employment and exacerbated his emotional and physical distress.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LDOS:US $41.31 USD -0.15

LDOS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Booz Allen Hamilton Holding Corp $27.40 USD -0.10
KBR Inc $18.11 USD +0.31
MasTec Inc $18.16 USD +0.07
Orbital ATK Inc $72.92 USD -0.55
View Industry Companies

Industry Analysis


Industry Average

Valuation LDOS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEIDOS HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at